{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P17813",
      "entity_text" : "end",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00423",
      "entity_text" : "vildagliptin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "At study end, A1C had decreased by -0.5% in the vildagliptin treated patients and -0.2% in the placebo group (P = 0.01).",
  "reading_complete" : "2020-07-28T15:24:44Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T15:23:22Z",
  "trigger" : "decreased",
  "evidence" : [ "end, A1C had decreased by -0.5% in the vildagliptin" ],
  "pmc_id" : "3920804",
  "score" : 0
}